您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > Phthalazinone pyrazole
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Phthalazinone pyrazole
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Phthalazinone pyrazole图片
CAS NO:880487-62-7
包装与价格:
包装价格(元)
5mg电议
10mg电议
25mg电议
50mg电议
100mg电议

产品介绍
Phthalazinone pyrazole 是一种有效的、选择性的、具有口服活性的Aurora-A激酶抑制剂,其IC50值为 0.031 μM。Phthalazinone pyrazole 可以阻止有丝分裂并随后通过增殖细胞的凋亡抑制肿瘤生长。Phthalazinone pyrazole 抑制人胚胎干细胞向肝细胞样细胞 (HLC) 分化过程中的上皮间质转化 (EMT)。
生物活性

Phthalazinone pyrazole is a potent, selective, and orally active inhibitor of Aurora-A kinase with anIC50of 0.031 μM. Phthalazinone pyrazole can arrests mitosis and subsequently inhibit tumor growth viaapoptosisof proliferating cells. Phthalazinone pyrazole suppresses the epithelial-mesenchymal transition (EMT) during the differentiation of hepatocyte-like cells (HLCs) from human embryonic stem cells[1][2].

IC50& Target

Aurora-A

0.031 μM (IC50)

体外研究
(In Vitro)

Phthalazinone pyrazole (1 and 10 μM; 30 hours) enhances the proliferative capacity of HLCs[2].
Phthalazinone pyrazole (1, 10, and 100 μM; 5 days) enhances hepatic morphological changes in differentiated HLCs without cytotoxicity[2].
Phthalazinone pyrazole (1 and 10 μM; 5 and 17 days) suppresses the EMT and induced maturation of HLCs through the inhibition of the AKT signaling pathway by the off target effect with concomitant upregulation of HNF4α rather than direct inhibition of Aurora-A. The result is confirmed by western blot and qPCR[2].

Cell Proliferation Assay[2]

Cell Line:Hepatocyte-like cells (HLCs)
Concentration:1 and 10 μM
Incubation Time:30 hours
Result:Enhanced the proliferative capacity of HLCs.

Cell Cytotoxicity Assay[2]

Cell Line:ES-HLCs, iPS-HLCs, Huh7 cells
Concentration:1, 10, and 100 μM
Incubation Time:5 days
Result:Showed no cytotoxic effects on HLCs.

Western Blot Analysis[2]

Cell Line:HLCs
Concentration:1 and 10 μM
Incubation Time:5 and 17 days
Result:Markedly inhibited the phosphorylation of AKT and activated GSK-3β, which in turn inhibited Snail expression and increased HNF4α. Phthalazinone pyrazole didn’t significantly reduce the phosphorylation of Aurora-A.

RT-PCR[2]

Cell Line:HLCs
Concentration:1 and 10 μM
Incubation Time:5 and 17 days
Result:Markedly inhibited the phosphorylation of AKT mRNA and activated GSK-3β mRNA, which in turn inhibited Snail mRNA expression and increased HNF4α mRNA. Phthalazinone pyrazole didn’t significantly reduce the phosphorylation of Aurora-A mRNA.
分子量

317.34

性状

Solid

Formula

C18H15N5O

CAS 号

880487-62-7

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

溶解性数据
In Vitro: 

DMSO : ≥ 11.11 mg/mL(35.01 mM)

*"≥" means soluble, but saturation unknown.

配制储备液
浓度溶剂体积质量1 mg5 mg10 mg
1 mM3.1512 mL15.7560 mL31.5119 mL
5 mM0.6302 mL3.1512 mL6.3024 mL
10 mM0.3151 mL1.5756 mL3.1512 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month (protect from light)。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。